BSP Biological Signal Processing Ltd.
7
0
0
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
43%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Usefulness of High-frequency QRS Analysis in the Evaluation of Patients With Chest Pain
Role: collaborator
The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing
Role: collaborator
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
Role: lead
Feasibility of High Frequency QRS Analysis in Patients With Acute Myocardial Infarction
Role: lead
Normal Values of High Frequency ECG (HyperQ™) in Apparently Healthy Individuals and in Young and Masters Athletes
Role: lead
Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography
Role: lead
Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG
Role: lead
All 7 trials loaded